The Acute Effect of Egg-Based High Protein Meal on Hypertensive Response to Exercise
NCT ID: NCT03073252
Last Updated: 2018-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
31 participants
INTERVENTIONAL
2017-01-01
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Increased, Egg-Based Protein Intake on Muscle Composition,
NCT01396915
Effect of Whey Protein on Blood Pressure
NCT00659672
Clinical Trial of Dietary Protein and Blood Pressure
NCT00046566
The Body's Response to Changes in Dietary Protein and Meal-Frequency In Men
NCT01171716
Clinical Trial of Protein and Blood Pressure
NCT00107744
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal Protein
Consumption of normal protein (NP) meal
Normal Protein
Consumption of a normal protein (NP), egg-based (13 g protein; whole eggs) breakfast bowl
HIgh Protein
Consumption of a high protein (HP), egg-based (30 g protein; whole eggs) breakfast bowl
High Protein
Consumption of high protein (HP) meal
Normal Protein
Consumption of a normal protein (NP), egg-based (13 g protein; whole eggs) breakfast bowl
HIgh Protein
Consumption of a high protein (HP), egg-based (30 g protein; whole eggs) breakfast bowl
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Normal Protein
Consumption of a normal protein (NP), egg-based (13 g protein; whole eggs) breakfast bowl
HIgh Protein
Consumption of a high protein (HP), egg-based (30 g protein; whole eggs) breakfast bowl
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 21
* Body weight \<300 lb (136 kg)
* BMI between 20 and 34.9 kg/m2
* Fasting plasma glucose \<6.1 mmol/L,
* total cholesterol \<6.7 mmol/L
* LDL cholesterol \<4.1 mmol/L
* TG \<4.5 mmol/L
* No pre-existing or history of cardiovascular, renal or liver disease
* Not currently or previously (past 6 mo) consuming a weight-loss diet or other special/non-balanced diets
* No weight loss/gain (±4.5 kg) within the past 6 mo
* No physical impairments preventing properly exercise execution
* No caffeine intake the day of testing
Exclusion Criteria
* Body weight ≥ 300 lb
* BMI \<20 or \>35 kg/m2
* Pregnant or planning pregnancy
* Unwilling to consume study foods and beverages
* Fasting plasma glucose ≥6.1 mmol/L
* Total cholesterol ≥6.7 mmol/L
* LDL cholesterol ≥4.1 mmol/L
* TG ≥4.5 mmol/L
* acute illness
* smoking
* diabetic
* pre-existing or history of cardiovascular, renal or liver disease
* currently or previously (past 6 mo) consuming a weight-loss diet or other special/non-balanced diets
* weight loss/gain (±4.5 kg) within the past 6 months
* physical impairments preventing properly exercise execution
* caffeine the day of testing
21 Years
121 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Purdue University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wayne Campbell
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Purdue University
West Lafayette, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1607017949
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.